Fifty-Microliter THC Blood Testing: Sensitivity Does Not Validate Every Collection Method

A validated assay quantified THC using only 50 microliters of whole blood. That analytical achievement does not independently validate roadside finger-prick collection or establish the meaning of a very low result for impairment.

The sensitivity finding

Researchers developed liquid–liquid extraction and LC–MS/MS for six cannabinoids. The lower quantification limit for THC was 0.10 ng/mL. Limits differed for other targets, so one sensitivity figure should not be applied to the entire panel.

The method measured liquid whole blood. Its compatibility with microsampling volumes is distinct from demonstrating that every collection device, capillary specimen and storage procedure produces interchangeable results.

Small preparation changes affected different analytes

Alkalinization improved response for several cannabinoids but slightly reduced THC-COOH response. Protein precipitation also helped some compounds while reducing others. Optimizing parent THC therefore did not automatically optimize its metabolites.

Instrument equilibration mattered too: extending it stabilized response across repeated injections after an initially shorter interval produced signal loss. Repeated injections are tests of analytical consistency, not additional independent human subjects.

Surrogate calibration required examination

The investigators used horse blood for calibration and assessed performance in three sources of drug-free human blood. They examined accuracy, precision, interferences and matrix behavior rather than simply assuming equivalence.

That validation supports the stated laboratory workflow. A different laboratory still needs evidence covering its equipment, specimen handling and collection conditions. Very-low-concentration findings also require careful attention to blanks, contamination and uncertainty.

What a lower quantification limit changes

Greater sensitivity expands the range of exposures a laboratory can measure. It does not make the lowest quantifiable concentration a clinical or legal boundary.

The study supports a practical small-volume assay, not an automatic classification of recent use, impairment or causation. The specimen, analyte and method must be reported accurately before any further interpretation is attempted.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

Aman A Mohammed and colleagues. Validation of a microsampling-compatible liquid–liquid extraction method for cannabinoid quantitation in 50 µL of whole blood using liquid chromatography–mass spectrometry. Journal of Analytical Toxicology (2026). DOI: 10.1093/jat/bkag004.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

A laboratory can identify a drug while relying on outside information to classify its prescription status. A national urine-testing study combined analytical results with medication information supplied by the ordering clinician. Two information streams McClure and colleagues analyzed 231,228 test-result sets from 144,535 patients tested for both opioids and benzodiazepines….

Spread the love

Read Article: How Did a Laboratory Study Decide That a Detected Drug Was Non-Prescribed?

How Did a Stress-Management Trial Protocol Handle Medication Changes?

When a study evaluates psychological treatment, medication changes can complicate attribution of improvement. The 2017 Seren@ctif protocol described how investigators planned to address this issue in a trial of adjustment disorder with anxiety. The planned comparison Servant and colleagues proposed three randomized groups receiving computer-based stress management, an equivalent face-to-face…

Spread the love

Read Article: How Did a Stress-Management Trial Protocol Handle Medication Changes?

What Evidence Supports Extending Lipid Rescue to a Different Poison?

A treatment that appears useful for one toxicant raises a separate scientific question when proposed for another. Eisenkraft and Falk’s 2016 review of lipid emulsion and chemical-agent poisoning provides an example of that evidence gap. Several evidence types The authors discussed proposed lipid-scavenging, metabolic, and cardiovascular mechanisms. They reviewed laboratory…

Spread the love

Read Article: What Evidence Supports Extending Lipid Rescue to a Different Poison?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us